Impact of Clazosentan on Vasospasm Reduction and Functional Recovery after Aneurysmal Subarachnoid Hemorrhage

Impact of Clazosentan on Vasospasm Reduction and Functional Recovery after Aneurysmal Subarachnoid Hemorrhage

In every hospital in Japan, until 2022, the primary treatment for preventing delayed cerebral ischemia (DCI) after aneurysmal subarachnoid hemorrhage (aSAH) involved a combination of ozagrel sodium (Oz), fasudil hydrochloride (Fs), cilostazol, and statins. However, with the approval of clazosentan i...

Full description

Saved in:
Bibliographic Details
Main Authors: Sosho KAJIWARA, Takayuki KAWANO, Yu HASEGAWA, Yukihiko NAKAMURA, Kiyohiko SAKATA, Jin KIKUCHI, Masaru HIROHATA, Motohiro MORIOKA
Format: Article
Language:English
Published: The Japan Neurosurgical Society 2025-01-01
Series:Neurologia Medico-Chirurgica
Subjects:
clazosentan
aneurysmal subarachnoid hemorrhage
delayed cerebral ischemia
vasospasm
Online Access:https://www.jstage.jst.go.jp/article/nmc/65/1/65_2024-0204/_pdf/-char/en
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items